Medtronic 2014 Annual Report Download - page 11

Download and view the complete annual report

Please find page 11 of the 2014 Medtronic annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 147

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147

device available for patients. LINQ is 80% smaller than other ICMs. In addition, it has 20% more data memory than its larger
predecessor, Reveal XT.
Services and Solutions. Given the market’s shift to value-based health care, we are expanding our medical device product
offerings to include broader health care services and solutions that provide meaningful clinical outcomes and economic value
for hospitals, physicians, patients, and payers. Such services and solutions include several different platforms. Our Cardiocom
products and services include remote monitoring and patient-centered software to enable efficient care coordination and
specialized telehealth nurse support. Our TYRX products include the recently U.S. FDA cleared AIGISRx R fully resorbable
antibacterial envelope and AIGISRx N antibacterial envelope, which are designed to reduce surgical site infections associated
with implantable pacemakers, defibrillators, and spinal cord neurostimulators. Our Cath Lab Managed Services business is
focused on developing novel partnerships with hospitals to provide services directly related to hospital operational efficiency.
The business is initially focused on offering services in Europe to manage and modernize catheterization lab (cath lab) facilities,
bringing sustainable efficiencies and programs to this critical area of hospital cardiology departments.
Patient Management Tools. We have a number of patient management tools, such as Patient Home Monitors, CareLink
Express, Paceart, and CardioSight Service. CareLink Express is the latest advancement in the care of Medtronic cardiac device
patients, enabling transmission of data from their pacemaker, ICD, CRT-D, or Insertable Cardiac Monitor using a portable
monitor that is connected to a standard telephone line. Paceart organizes and archives data for cardiac devices from major
device manufacturers, serving as the central hub for patients’ device data. CardioSight Service is an in-clinic data access tool
available to physicians treating heart failure patients who have one of several types of Medtronic CRT-Ds or ICDs. Patient
Home Monitors transfer data from pacemakers, ICDs, and CRT-Ds from patients’ homes to a web-based system that their health
care provider can view.
The charts below set forth net sales of our CRDM products as a percentage of our total net sales for each of the last three fiscal
years:
31%
69%
Fiscal Year 2012
(dollars in millions)
30%
70%
Fiscal Year 2013
(dollars in millions)
All Other
$11,668
All Other
$11,177
29%
71%
Fiscal Year 2014
(dollars in millions)
All Other
$12,009
CRDM
$4,996
CRDM
$4,922
CRDM
$5,007
Customers and Competitors
The primary medical specialists who use our CRDM products include electrophysiologists, implanting cardiologists, heart
failure specialists, and cardiovascular surgeons. Our primary competitors in the CRDM business are St. Jude Medical, Inc.
(St. Jude), Boston Scientific Corporation (Boston Scientific), Biotronik, Inc., and Sorin Group (Sorin).
Coronary
Coronary includes therapies to treat coronary artery disease (CAD) and hypertension. The products contained within this
business include coronary stents and related delivery systems, including a broad line of balloon angioplasty catheters, guide
catheters, guidewires, diagnostic catheters, and accessories.
The following are the principal products offered by our Coronary business:
Percutaneous Coronary Intervention (PCI). PCI encompasses a variety of procedures used to treat patients with CAD. CAD
is commonly treated with balloon angioplasty, which is performed to open narrowed heart vessels by inserting a balloon
catheter into the vessel and advancing it to the site of the blockage where it is inflated to widen the obstructed vessel. Balloon
angioplasty can be followed up with a coronary stent, a support device which works as scaffolding to keep the vessel open
3